Characterization of proptosis response in the thrive phase 3 trial of veligrotug for active thyroid eye disease (TED)
Patrice Rodien, Garrido-Hermosilla Antonio Manuel, Peerooz Saeed, Michael Schittkowski et autres
0 citationsEndocrine Abstracts
Abhijit Narvekar
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
25Publications signalées
202Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Ocular Surface and Contact LensOcular Infections and TreatmentsAllergic Rhinitis and SensitizationRetinal and Optic ConditionsGlaucoma and retinal disorders
Publications récentes
Thrive-2 phase 3 trial of veligrotug in chronic thyroid eye disease (TED): efficacy, safety, and quality of life at week 15
Garrido-Hermosilla Antonio Manuel, Anja Eckstein, Onur Konuk, Adrienne Csutak et autres
0 citationsEndocrine Abstracts
THRIVE
Michael T. Yen, Kimberly Cockerham, Peerooz Saeed, Steven Leibowitz et autres
1 citationOphthalmology
Efficacy and safety of veligrotug (VRDN-001), a full antagonist monoclonal antibody to IGF-1 receptor, in active thyroid eye disease (TED): THRIVE phase 3 topline results
Patrice Rodien, H Garrido, Peerooz Saeed, Michael Schittkowski et autres
0 citationsEndocrine Abstracts
THRIVE-2 phase 3 trial of Veligrotug (VRDN-001) in chronic thyroid eye disease (TED): efficacy and safety at 15 weeks
Patrice Rodien, Michael Schittkowski, Onur Konuk, Anja Eckstein et autres
0 citationsEndocrine Abstracts
Nanoparticles for the Treatment of Uveal Melanoma
Abhijit Narvekar, Cadmus Rich, Anneli Savinainen, Ivana K. Kim
3 citations
Content validity of a novel patient-reported and observer-reported outcomes assessment to evaluate ocular symptoms associated with infectious conjunctivitis in both adult and pediatric populations
Sujata P. Sarda, Marie de la Cruz, Emuella Flood, Magdalena Vanya et autres
6 citationsHealth and Quality of Life Outcomes
Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis
Jay S. Pepose, Arjun Ahuja, Wenlei Liu, Abhijit Narvekar et autres
9 citationsAmerican Journal of Ophthalmology
A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis
Jay S. Pepose, Abhijit Narvekar, Wenlei Liu, Reza Haque
26 citationsClinical ophthalmology
A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis
Pepose JS, Abhijit Narvekar, Wu Liu, Reza Haque
0 citationsDigital Commons@Becker (Washington University School of Medicine)
Reply
Jay S. Pepose, Arjun Ahuja, Wenlei Liu, Abhijit Narvekar et autres
0 citationsAmerican Journal of Ophthalmology
A phase 2, randomized, controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for the treatment of adenoviral conjunctivitis
Robert D. Gross, Jay S. Pepose, Abhijit Narvekar, Arjun Ahuja et autres
0 citationsJournal of American Association for Pediatric Ophthalmology and Strabismus
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.